Aemetis (NASDAQ:AMTX – Get Free Report) posted its quarterly earnings data on Tuesday. The specialty chemicals company reported ($0.38) EPS for the quarter, beating analysts’ consensus estimates of ($0.47) by $0.09, Zacks reports. The company had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the prior year, the business earned ($0.59) EPS.
Aemetis Price Performance
Aemetis stock traded down $0.34 during midday trading on Wednesday, reaching $4.28. The stock had a trading volume of 806,190 shares, compared to its average volume of 802,842. The firm’s fifty day simple moving average is $2.70 and its two-hundred day simple moving average is $3.05. Aemetis has a twelve month low of $2.10 and a twelve month high of $7.03. The firm has a market cap of $202.02 million, a price-to-earnings ratio of -3.74 and a beta of 1.23.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on AMTX. Ascendiant Capital Markets lowered their price objective on shares of Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. Truist Financial reiterated a “hold” rating and set a $3.50 price objective (down previously from $4.00) on shares of Aemetis in a research note on Wednesday, July 31st. HC Wainwright reiterated a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research note on Friday, August 2nd. StockNews.com upgraded shares of Aemetis to a “sell” rating in a report on Wednesday, July 31st. Finally, UBS Group reduced their target price on shares of Aemetis from $8.25 to $7.75 and set a “buy” rating for the company in a report on Monday, August 19th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Aemetis presently has an average rating of “Moderate Buy” and an average price target of $12.95.
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
See Also
- Five stocks we like better than Aemetis
- 3 Warren Buffett Stocks to Buy Now
- Rocket Lab is the Right Stock for the Right Time
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- 3 REITs to Buy and Hold for the Long Term
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.